First Chronic Hepatitis B Patient Dosed in China in a Phase I Trial of T101 (Transgene’s TG1050 Technology) Life Science
Exclusive: J&J attracts Chinese interest for diabetes business in potential $3-4 billion deal – sources Life Science
Xbrane Biopharma Clarifies Information Regarding Letter of Intent With CR Pharma Considering Xlucane Life Science
China Investment Corp’s President Tu Guangshao Calls US To Export More American Tech To China Technology